423 related articles for article (PubMed ID: 20516049)
1. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.
Su WJ; Feng JY; Chiu YC; Huang SF; Lee YC
Eur Respir J; 2011 Feb; 37(2):376-83. PubMed ID: 20516049
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
3. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
Ambreen A; Jamil M; Rahman MAU; Mustafa T
BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
[TBL] [Abstract][Full Text] [Related]
4. Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon.
Kuaban C; Bame R; Mouangue L; Djella S; Yomgni C
East Afr Med J; 2009 May; 86(5):219-25. PubMed ID: 20084990
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
[TBL] [Abstract][Full Text] [Related]
6. Relative versus absolute noncontagiousness of respiratory tuberculosis on treatment.
Long R; Bochar K; Chomyc S; Talbot J; Barrie J; Kunimoto D; Tilley P
Infect Control Hosp Epidemiol; 2003 Nov; 24(11):831-8. PubMed ID: 14649771
[TBL] [Abstract][Full Text] [Related]
7. Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB.
Chien JY; Chen YT; Shu CC; Lee JJ; Wang JY; Yu CJ; Yang PC
Chest; 2013 Jun; 143(6):1725-1732. PubMed ID: 23288018
[TBL] [Abstract][Full Text] [Related]
8. Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.
Parikh R; Nataraj G; Kanade S; Khatri V; Mehta P
J Assoc Physicians India; 2012 Aug; 60():22-6. PubMed ID: 23405517
[TBL] [Abstract][Full Text] [Related]
9. [In 76% of patients with active tuberculosis treated with triple therapy (isoniazid-rifampicin-pyrazinamide) cultural conversion precedes microscopic conversion].
Nowak D; Radenbach D; Magnussen H
Pneumologie; 1990 Feb; 44 Suppl 1():497-8. PubMed ID: 2114634
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and outcome of tuberculosis patients whose sputum smears are positive at or after 5 months of treatment.
Harries AD; Gausi F; Chimzizi R; Salaniponi FM
Int J Tuberc Lung Dis; 2004 Mar; 8(3):384-7. PubMed ID: 15139479
[TBL] [Abstract][Full Text] [Related]
11. Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Prevalence and significance of negative smears pretreatment and positive smears post-treatment.
Kim TC; Blackman RS; Heatwole KM; Kim T; Rochester DF
Am Rev Respir Dis; 1984 Feb; 129(2):264-8. PubMed ID: 6421211
[TBL] [Abstract][Full Text] [Related]
12. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
[TBL] [Abstract][Full Text] [Related]
13. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
Tiwari S; Kumar A; Kapoor SK
Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
[TBL] [Abstract][Full Text] [Related]
14. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
[TBL] [Abstract][Full Text] [Related]
15. Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
Rockwood N; Pasipanodya JG; Denti P; Sirgel F; Lesosky M; Gumbo T; Meintjes G; McIlleron H; Wilkinson RJ
Clin Infect Dis; 2017 May; 64(10):1350-1359. PubMed ID: 28205671
[TBL] [Abstract][Full Text] [Related]
16. Prolonged positivity of sputum smears with negative cultures during treatment for pulmonary tuberculosis.
van der Kuyp F; Mahan CS
Int J Tuberc Lung Dis; 2012 Dec; 16(12):1663-7. PubMed ID: 23131266
[TBL] [Abstract][Full Text] [Related]
17. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
Kurbatova EV; Gammino VM; Bayona J; Becerra MC; Danilovitz M; Falzon D; Gelmanova I; Keshavjee S; Leimane V; Mitnick CD; Quelapio MI; Riekstina V; Taylor A; Viiklepp P; Zignol M; Cegielski JP
Int J Tuberc Lung Dis; 2012 Oct; 16(10):1335-43. PubMed ID: 23107633
[TBL] [Abstract][Full Text] [Related]
18. Association of serum levels of iron, copper, and zinc, and inflammatory markers with bacteriological sputum conversion during tuberculosis treatment.
Moraes ML; Ramalho DM; Delogo KN; Miranda PF; Mesquita ED; de Melo Guedes de Oliveira HM; Netto AR; Dos Anjos MJ; Kritski AL; de Oliveira MM
Biol Trace Elem Res; 2014 Aug; 160(2):176-84. PubMed ID: 24958018
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study.
Suárez-Méndez R; García-García I; Fernández-Olivera N; Valdés-Quintana M; Milanés-Virelles MT; Carbonell D; Machado-Molina D; Valenzuela-Silva CM; López-Saura PA
BMC Infect Dis; 2004 Oct; 4():44. PubMed ID: 15500691
[TBL] [Abstract][Full Text] [Related]
20. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
